Tau-mediated synaptic damage in Alzheimer's disease

Area of Science:

• Neuroscience
• Cell Biology
• Neuropathology

Background:

• Synapses are crucial for neuronal communication and brain function.
• Alzheimer's disease (AD) and tauopathies involve the accumulation of abnormal tau protein.
• Emerging evidence suggests AD is fundamentally a synaptic disorder.

Purpose of the Study:

• To investigate the role of pathological tau protein in synaptic dysfunction in tauopathies.
• To explore the link between tau pathology and synaptic loss in cognitive impairment.

Main Methods:

• Review of structural, transcriptomic, and proteomic studies.
• Analysis of transgenic tauopathy models.
• Correlation of tau lesion distribution with synaptic loss and cognitive deficits.

Main Results:

• Tau pathology correlates strongly with synaptic loss and cognitive impairment in AD and tauopathies.
• Transgenic models exhibit structural synaptic deficits due to tau expression.
• Pathological tau dysregulates synaptic proteome, impairing synaptic transmission.

Conclusions:

• Tau protein is a key mediator of synaptic impairment in human tauopathies.
• Alzheimer's disease is characterized by synaptic dysfunction driven by tau pathology.
• Targeting tau may offer therapeutic strategies for synaptic restoration in dementia.